Impact of most promising Ebola therapies on survival: a secondary analysis during the tenth outbreak in the Democratic Republic of Congo

Impact of most promising Ebola therapies on survival: a secondary analysis during the tenth outbreak in the Democratic Republic of Congo

Abstract Background MAb114, REGN-EB3, Remdesivir, and ZMapp, which are monoclonal antibody-based treatments, have been compared and shown to be promising therapies against the Ebola Virus Disease (EVD). There has been no comparison between these medications and standard treatment (without antiviral)...

Full description

Saved in:
Bibliographic Details
Main Authors: Esther Mamu Kikwango, Pierre Z. Akilimali, Nguyen Toan Tran
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Virology Journal
Subjects:
Promising therapies
Ebola virus disease
ZMapp
Remdesivir
REGN EB3
mAb114
Online Access:https://doi.org/10.1186/s12985-025-02766-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12985-025-02766-y

Similar Items